Molecular Wellness Testing. Powered by Biomeme.
The same platform that identifies biological threats and distinguishes bacterial from viral infections can now monitor your molecular response to therapy — in real time.
Your genes don't change. But gene expression does — every day, in response to medication, diet, stress, and disease. We measure it.
Three Verbs. One Platform.
Transcriptomic wellness testing isn't a single snapshot. It's a longitudinal molecular journey.
Predict
Know how your body is likely to respond before starting a treatment. Genetic markers flag predispositions. Expression baselines establish your starting point.
Confirm
Verify the treatment is engaging molecular targets — don't wait months for clinical results. Gene expression changes appear weeks before weight, labs, or symptoms shift.
Monitor
Detect molecular drift before clinical symptoms appear. Longitudinal monitoring catches treatment fatigue, regain risk, and response changes early — so you can adapt proactively.
One Platform. Many Applications.
Every wellness panel runs on the same Biomeme/5 instrument and processing pipeline. Adding a new indication doesn't require new hardware — just new assay design.
GLP-1 / Weight Management
Inflammatory resolution, lipogenic suppression, metabolic adaptation. Predict, confirm, and monitor GLP-1 therapeutic response at the molecular level.
19 targets · 4-node longitudinal system
Launching now
Peptide Therapy
BPC-157, Thymosin Beta-4, and other therapeutic peptides. Track tissue repair markers and inflammatory response to confirm peptide efficacy at the molecular level.
Signature in development
Hormonal Health
HPA axis markers, thyroid response genes, cortisol signaling. Monitor how hormonal interventions are engaging at the transcriptomic level.
Use case under evaluation
Dermatology
Skin barrier gene expression, inflammatory cascades, and treatment response markers for conditions like eczema, psoriasis, and chronic inflammatory skin disease.
Use case under evaluation
Metabolic Health
Insulin signaling, lipid metabolism, and mitochondrial function. A comprehensive metabolic snapshot beyond standard blood panels — catching shifts weeks before traditional markers move.
Use case under evaluation
Autoimmune Monitoring
Cytokine profiles, immune pathway activation, and flare risk tracking. Longitudinal gene expression monitoring for treatment response and disease management.
Use case under evaluation
How Molecular Monitoring Works
A seamless, end-to-end pipeline from sample collection to actionable biological insight.
Sample Collection
Non-invasive collection using Biomeme's proprietary stabilization buffer. No cold chain required.
Platform Processing
Samples are processed on the Biomeme/5 platform by One Health Labs for clinical-grade precision.
Automated Analysis
Algorithms quantify transcriptomic changes directly on the instrument, securely syncing final results.
Actionable Insights
Partners receive clear, longitudinal reporting on therapeutic efficacy and patient molecular response.
One Instrument. Any Panel.
Every wellness application above runs on the same hardware: the Biomeme/5, a portable instrument capable of measuring up to 48 molecular targets in a single run.
Adding a new wellness panel doesn't require new equipment — just new assay design. That means the platform scales across indications while the per-test economics improve with every panel we add.
As Biomeme's dedicated clinical testing arm, One Health Labs processes all wellness panels in a high-throughput, CLIA-certified environment—bridging the gap between our hardware engineering and your clinical-grade results.
Why Transcriptomics?
Unlike static genetic tests that tell you what you were born with, transcriptomic markers change in real time — giving you a molecular snapshot of what's happening right now.
Gene expression responds to medication, diet, stress, and disease weeks before traditional blood panels, weight measurements, or clinical symptoms change. That's not a marginal improvement — it's a fundamentally different category of insight.
Learn About TranscriptomicsGenomics
Static
What you have
Transcriptomics
Dynamic
What's active
Proteomics
Slow
Lab only
Have a Use Case? Let's Build It.
We partner with researchers, therapeutics companies, and clinical organizations to develop custom transcriptomic signatures on our platform. If you have a therapeutic area that needs molecular monitoring, we'd love to talk.
Assay development — We design multiplexed panels for your target analytes.
Validation support — CLIA-certified lab for clinical validation and testing.
Full deployment — From signature development to consumer-facing dashboard and reporting.
"The future of wellness is proactive. Proactive health demands precision insights. Precision insights demand transcriptomics. And transcriptomics is powered by Biomeme."
The Biomeme Wellness Thesis
Don't Guess. Measure Your GLP-1 Response.
The GLP-1 Response Panel is launching soon.